欧洲疾控中心-从疫区返回的献血者登革热病毒的延期标准和检测策略（英）-2025.8

Deferral criteria and testing strategies for dengue virus in blood donors returning from To support discussions with the ECDC network on substances of human origin (SoHO-Net), ECDC conducted a核心数据:While 91% of the responding EU/EEA countries have deferral criteria for blood donors returning from dengueendemic areas, only 55% have specific criteria for those returning from affected non-endemic areas within the;The clinical manifestations of dengue range from mild, asymptomatic infections to severe and potentially lifethreatening conditions. It is reported that 60–80% of individuals infected with DENV will remain asymptomatic;infection ranged from 0 to 42% of cases (median 7.5%, six studies) for the ‘no symptoms’ category; 0 to 100%。

覆盖 2025 年,全文约 15。

本报告免费查阅,登录资料宝后即可在线获取完整内容。

适合战略规划、行业研究员等读者参考。

重点分析了管理咨询等议题。